Human Growth Hormone Market 2027 Size, Share, Trends, Growth, Regional Outlook And Forecast to 2027
Coherent Market Insights has recently updated its massive report catalog by adding a fresh study titled “Global Human Growth Hormone Market – Industry Analysis, Size, Share, Growth, Trends, & Forecast 2021 – 2027”. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2027. The report also targets important facets such as market drivers, challenges, latest trends, and opportunities associated with the growth of manufacturers in the global market for Human Growth Hormone. Along with these insights, the report provides the readers with crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.
Human growth hormones are a peptide hormone that stimulate growth, cell regeneration, and cell reproduction, in humans along with animals. Somatotropic cells are responsible to secrete and store growth hormones within the anterior pituitary gland’s lateral wings. Growth hormones functions include growing height through childhood, increased calcium retention, strengthening and increasing bone mineralization, increased muscle mass from sarcomere hypertrophy, increases protein synthesis, stimulates every internal organ’s growth excluding the brain, promotes lipolysis, vital for homeostasis, reduces glucose uptake of liver, increases T3 to T4 DE iodination, and stimulates immune system. Excess growth hormone secretion leads to pituitary tumor, consisting anterior pituitary’s somatotroph cells. The somatotroph cells grow slowly and are benign, producing excess growth hormones. It results in headaches, impaired vision due to pressure on optic nerves, other hormone deficiency secreted from pituitary gland, along with thickening of bones of toes, fingers, and jaw, which ultimately results in jaw heaviness and growth in digits named acromegaly’s size. Acromegaly leads to pressure upon nerves, decreased sexual function and muscle weakness. The growth hormone deficiency causes failure within growth, rise in osteoclast activities, trauma, bone weakening, increase within fat mass, along with reduction within muscle mass.
Global Human Growth Hormone Market Drivers:-
Increasing acquisitions and mergers are expected to drive growth of the global human growth hormone market over the forecast period. For instance, a pharmaceutical company based in U.S. – Pfizer Inc., in 2014, merged with the U.S.-based OPKO Health Inc., for developing a growth hormone (hGH-CTP) which is long acting along with bringing innovative treatments for patients of growth hormone deficiency. hGH-CTP has more convenience, since only one injection needs to be taken by the patients in a week instead of daily doses. hGH-CTP has the orphan drug designation within Europe and the U.S. for children and adults with deficiency of growth hormone.
Strong pipeline is expected to accelerate the global human growth hormone market growth over the forecast period. For instance, the Denmark-based Somapacitan sponsored by Novo Nordisk A/S, in 2017, completed clinical trials of phase III. The drug is used to treat deficiency of growth hormone in adults. The Israel-based MOD-4023 sponsored by Opko Biologics, in 2015completed clinical trials of phase 2. Growth hormone deficiency’s high prevalence is another aspect expected to boost the global human growth hormone market growth. In 2015, as per the National Organization for Rare Diseases (NORD) conducted survey, around 50,000 adults and 10,000 children have deficiency of growth hormone within the U.S.
However, stringent regulations for the human growth hormone usage by sports professionals and athletes is expected to hamper the global human growth hormone market growth. In 2006, the U.S. Food and Drug Administration (FDA) along with the International Olympic Committee, banned the human growth hormone use for sports professionals.
Global Human Growth Hormone Market: Regional Analysis:-
North America is expected to account for the highest share in the global human growth hormone market, owing to latest biosimilar approvals for drugs of human growth hormone’s biosimilar from Health Canada. For instance, the first generic biological named as PROmnitrope was approved by Health Canada, in 2015. The PROmnitrope is the recombinant human growth hormone utilized for treating growth hormone deficiency in adults along with in children. This could encourage drugs’ latest generic version, thereby expected to fuel growth of the global human growth hormone market.
Europe market is expected to register robust growth, owing to acquisitions and mergers. For instance, Ferring Pharmaceuticals S.A., in 2017, acquired the Antares Pharma Inc.’s Zoma Jet product. Zoma Jet is an auto injectable needle free device. Zoma Jet is utilized for delivering Zomacton to treat deficiency of growth hormone in children and the Turner’s syndrome within girls. Through this acquisition the Zoma Jet device, would ultimately lead to rise in Zomacton dug’s use, which would further support Ferring Pharmaceuticals for developing better options for treatment for deficiency of growth hormone, thereby expected to propel the global human growth hormone market growth.
Asia Pacific is expected to witness growth over the forecast period owing to strong pipeline. For instance, Iran-based Cinna Tropin sponsored by Cinnagen, completed clinical trials of phase 3 in 2017. The drug is used for treatment of idiopathic short stature within adults and children.
Global Human Growth Hormone Market Taxonomy:-
On the basis of Application
-
Idiopathic short stature
-
Turner Syndrome
-
Growth Hormone Deficiency
-
Prader-Willi Syndrome
-
Others
On the basis of Route of Administration
-
Intravenous
-
Subcutaneous
-
Oral
-
Intramuscular
On the basis of Distribution Channel
-
Retail Pharmacies
-
Hospitals
-
Online Pharmacies
On the basis of Region
-
North America
-
Latin America
-
Europe
-
Africa
-
Asia Pacific
-
Middle East
Major Key Players Include In Human Growth Hormone Market: Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen.
Buy instant copy of this research report with Flat US $ 2000 Off@ – https://www.coherentmarketinsights.com/promo/buynow/1859
Main points in Human Growth Hormone Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Human Growth Hormone Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Human Growth Hormone Industry Impact
Chapter 2 Global Human Growth Hormone Competition by Types, Applications, and Top Regions and Countries
2.1 Global Human Growth Hormone (Volume and Value) by Type
2.3 Global Human Growth Hormone (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Human Growth Hormone Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Human Growth Hormone Market Analysis
Chapter 6 East Asia Human Growth Hormone Market Analysis
Chapter 7 Europe Human Growth Hormone Market Analysis
Chapter 8 South Asia Human Growth Hormone Market Analysis
Chapter 9 Southeast Asia Human Growth Hormone Market Analysis
Chapter 10 Middle East Human Growth Hormone Market Analysis
Chapter 11 Africa Human Growth Hormone Market Analysis
Chapter 12 Oceania Human Growth Hormone Market Analysis
Chapter 13 South America Human Growth Hormone Market Analysis
Chapter 14 Company Profiles and Key Figures in Human Growth Hormone Business
Chapter 15 Global Human Growth Hormone Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Editor Details
-
Company:
- CDN Newswire
